The Effect of the Compound of Tomato Extract to the Prostatic Cancer Cell and the Prostate of the Rat Model of Benign Prostatic Hyperplasia
![]() |
Kang, Han-Saem
(ECOBIO INC.)
Kim, Gwang-Yun (ECOBIO INC.) Jung, Il (ECOBIO INC.) Oh, Sung-Dug (ECOBIO INC.) Kim, Chang-Hoon (ECOBIO INC.) Shim, Bong-Sup (ECOBIO INC.) Park, Keun-Hyung (Department of Biological & Environmental Chemistry, College of Agriculture and Life Sciences) Oh, Suk-Jung (ECOBIO INC.) |
1 | Rhoehrborn, C. G., Marks, L., Harkaway, R. (2006) Enlarged prostate: A landmark national survey of its prevalence and impact on US men and their partners. Prostate Cancer Prostatic Dis 9: 30-34 DOI ScienceOn |
2 | Nixon, P. (1997) New clinical trial of medical therapy for benign prostatic hyperplasia. Drug Benefit Trends 9: 44-45 |
3 | Lehle, C., Radvanyi, F., Gil Diez de Medina, S. (1999) Differences in steroid 5 alpha-reductase iso-enzymes expression between normal and pathological human prostate tissue. J Steroid Biochem Mol Biol 68: 189-195 DOI ScienceOn |
4 | Okamoto, Y., Inoue, A., Miyatake, K., Ogihara, K., Shigemasa, Y., Minami, S. (2003) Effects of chitin/shitosan and their oligomers/monomers on migrations of macrophages. Macromol Biosci 3: 587-590 DOI ScienceOn |
5 | Tokoro, A., Tatewaki, N., Suzuki, K., Mikami, T., Suzuki, S., Suzuki, M. (1998) Growth inhibitory effect of hexa-N-acetylchitohexaose and chitohexaos and Meth-A solid tumor. Chem Pharm Bull 36: 784-790 |
6 | Jeon, T. I., Hwang, S. G., Park, N. G., Jung, Y. R., Shin, S. I., Choi, S. D., Park, D. K. (2003) Antioxidative effect of chitosan on chronic carbon tetrachloride induced hepatic injury in rats. Toxicology 187: 67-73 DOI ScienceOn |
7 | Karr, J. P., Kim, U., Resko, J. A., Schneider, S., Chai, L. S., Murphy, G. P., Sandbery, A. A. (1984) Induction of benign prostatic hypertrophy in baboons. Urology 23: 276-289 DOI ScienceOn |
8 | Giovannucci, E., Rimm, E. B., Liu, Y., Stampfer, M. J., Willett, W. C. (2002) A prospective study of tomato products, lycopene, and prostate cancer risk. J Natl Cancer Inst 94: 391-398 DOI ScienceOn |
9 | Coffey, D. S., Walsh, P. C. (1990) Clinical and experimental studies of benign prostatic hyperplasia. Urol Clin North Am 17: 461-475 |
10 | Silver, R. I., Wiley, E. L., Davis, D. L., Thigpen, A. E., Russell, D. W., McConnell, J. D. (1994) Expression and regulation of steroid 5 alpha-reductase 2 in prostate disease. J Urol 152: 433-437 DOI |
11 | Bales, G. T., Christiano, A. P., Kirsh, E. J., Gerber, G. S. (1999) Phytotherapeutic agents in the treatment of lower urinary track symptoms: a demographic analysis of awareness and use at the University of Chicago. Urology 54: 86-89 DOI ScienceOn |
12 | Berry, S. J., Coffey, D. S., Strandberg, J. D., Ewing, L. L. (1986) Effect of age, castration and testosterone replacement on the development and restoration of canine benign prostatic hyperplasia. Prostate 9: 295-302 DOI ScienceOn |
13 | Pannala, A. S., Rice-Evans, C., Sampson, J., Sin, S. (1998) Interaction of peroxynitrite with carotenoids and tocopherols within low density lipoprotein. FEBS Letters 423: 297-301 DOI ScienceOn |
14 | Friendman, M. (2002) Tomato glycoalkaloids: role in the plant and in the diet. J Agric Food Chem 50: 5751-5760 DOI ScienceOn |
15 | Siler, U., Barella, L., Spitzer, V., Schnorr, J., Lein, M., Goralczyk, R., Wertz, K. (2004) Lycopene and vitamin E interfere with autocrine/paracrine loops in the dunning prostate cancer model. FASEB J 14: 1-23 |
16 | Wilt, T. J., Ishani, A., Stark, G. (1998) Saw palmetto extracts for treatment of benign prostatic hyperplasia: a systematic review. JAMA 280: 1604-1609 DOI ScienceOn |
17 |
Clark, R. V., Hermann, D. J., Cunningham, G. R., Wilson, T. H., Morrill, B. B., Hobbs, S. (2004) Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5 |
18 | Gerasimenko, D. V., Avdienko, I. D., Bannikova, G. E., Zueva, O. Y., Varlamov, V. P. (2004) Antibacterial effects of water-soluble low-molecular-weight chitosans on different microorganisms. Appl Biochem Microbiol 40: 253-257 DOI |
19 | Di Mascio, P., Kaiser, S., Sies, H. (1989) Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Arch Biochem Soc Trans 24: 1023-1027 |
20 | Isaacs, J. T. (1984) Antagonistic effect of androgen on prostatic cell death. Prostate 5: 545-557 DOI ScienceOn |
21 | Xing, N., Chen, Y., Mitchell, S. H., Young, C. V. (2001) Quercetin inhibits the expression and function of the androgen receptor in LNCaP prostate cancer cells. Carcinogenesis 22: 409-414 DOI ScienceOn |
22 | Wilt, T. J., MacDonald, R., Ishani, A. (1999) Beta-sisterol for the treatment of benign prostatic hyperplasia: a systematic review. BJU International 83: 976-983 DOI |
23 | Constantinou, C. E. (1996) Influence of hormone treatment on prostate growth and micturition characteristics of the rat. Prostate 26: 30-35 |
24 | Bonkhoff, H., Stein, U., Aumuller, G., Remberger, K. (1996) Differential expression of 5 alpha-reductase isoenzymes in the human prostate and prostatic carcinomas. Prostate 29: 261-267 DOI ScienceOn |
25 | Schroeder, F. H. (1983) Current models and their relation to human diseases. In Hinman, F. (ed.), Benign prostatic hypertophy, 215-228. Springer Verlag, New York, USA |
26 | Jameela, S. R., Misra, A., Jayakrishnan, A. (1994) Cross-linked chitosan microspheres as carriers for prolonged delivery of macromolecular drugs. J Biomater Sci Polym Ed 6: 621-632 DOI ScienceOn |
27 | Kotakanara, E., Kushiro, M., Zhang, H., Sugawara, T., Myashita, K., Nagao, A. (2001) Carotenoids affect proliferation of human prostate cancer cells. J Nutr 131: 3303-3306 |
28 | Di Silverio, F., Flammia, G. P., Sciarra, A. (1993) Plant extracts in benign prostatic hyperplasia, Minerva Urol Nefrol 45: 143-149 |
29 | AUA Practice Guidelines Committee. (2003) AUA guideline on management of benign prostatic hyperplasia, Chapter 1: Diagnosis and treatment recommendations. J Urol 170: 530-547 DOI ScienceOn |
30 | Buck, A. C. (1996) Phytotherapy for the prostate. Br J Urol 78: 325-326 DOI ScienceOn |
![]() |